Publicacions en col·laboració amb investigadors/es de Universidad de Castilla-La Mancha (8)

2022

  1. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis

    Therapeutic Advances in Medical Oncology, Vol. 14

2021

  1. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. Crocetin isolated from the natural food colorant saffron reduces intracellular fat in 3T3-L1 adipocytes

    Foods, Vol. 9, Núm. 11

2019

  1. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer

    Nanomaterials, Vol. 9, Núm. 12

2011

  1. A proteomic analysis of PKCε targets in astrocytes: Implications for astrogliosis

    Amino Acids, Vol. 40, Núm. 2, pp. 641-651

2007

  1. ER-stress apoptotic signalling in ischemic astrocytes depends on Caspase-11 activation

    NEURON GLIA BIOLOGY

  2. Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: Modulation of cytotoxicity by nitric oxide

    Molecular Pharmacology, Vol. 72, Núm. 2, pp. 407-417